Summary
Latest filing:
Lidia Fonseca is Director of Medtronic plc (MDT). 3 SEC Form 4 filings on record, most recently on 29 April 2026.
Recent transactions
5The latest 5 SEC Form 4 transactions reported by Lidia Fonseca.
Trading pattern
InsiderAlpha's records for Lidia Fonseca go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lidia Fonseca files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harry Skip Kiil - $5.61M in MDT purchases and sales in the last 12 months
- Gregory L. Smith - $3.06M in MDT purchases and sales in the last 12 months
- Albert Bourla - $1.00M in PFE purchases and sales in the last 12 months
- Ronald E. Blaylock - $999K in PFE purchases and sales in the last 12 months
- Mortimer J. Buckley - $960K in PFE purchases and sales in the last 12 months
- Matthew R. Walter - $258K in MDT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lidia Fonseca?
Lidia Fonseca is a corporate insider, tracked as Director of Medtronic plc (MDT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Lidia Fonseca last file a Form 4?
The most recent primary Form 4 on record is dated 29 April 2026, one of 3 filings going back to 2026.